DWP 09031
Alternative Names: DWJ-302; DWP09031Latest Information Update: 28 Jun 2024
At a glance
- Originator Daewoong Pharmaceutical
- Class Small molecules
- Mechanism of Action Amyloid beta-protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 28 Jun 2024 No recent reports of development identified for phase-I development in Alzheimer's-disease(In volunteers) in South Korea (PO)
- 16 Jun 2022 DWP 09031 is still in phase-I development in Alzheimer's-disease (In volunteers) in South Korea (PO)
- 28 Apr 2018 No recent reports of development identified for phase-I development in Alzheimer's-disease(In volunteers) in South Korea (PO)